| Cure | Completed full course of antituberculosis chemotherapy within 12 months of starting treatment or notification and documented culture conversion in sputum positive patients during treatment (ie, culture positive at start of treatment becoming culture negative) |
| Completion | Completed full course of therapy within 1 year of starting treatment/notification |
| Treatment stopped | Patient found to have stopped treatment (by himself) or any other reason not mentioned below |
| Death | Patients who die while on treatment for tuberculosis or who were diagnosed post mortem or died without starting treatment |
| |
| Still on treatment at 1 year: patient who is still on treatment at 1 year because: |
| (a) Initially planned course | Regimen of 12 months or longer was planned at start of treatment (eg, CNS tuberculosis or drug resistant disease) |
| (b) Interruption | Non-completion of a treatment regimen initially planned to last 12 months or less (but still taking initially planned combination of drugs) as a result of: |
| interruption due to intolerance/side effects |
| drug intake less than 80% of prescribed dose |
| other interruption in taking prescribed treatment for 2 months or longer |
| (c) Change | A change and/or extension of the drug regimen as a result of (select one or more): |
| intolerance/side effects |
| initial drug resistance |
| development of new drug resistance (change in drug susceptibilities during current treatment episode) |
| failure to culture convert |
| poor clinical response to treatment |
| |
| Lost to follow-up | Patient lost to follow-up before the end of treatment |
| Transferred out | Responsibility for patient’s care transferred to another clinical team |
| Unknown | No treatment details available (eg, lost patient notes) |